Filter
700
Filtered Results: 700
Text search:
biosafety
Featured
Recommendations
109
New Publications
162
Language
Document type
No document type
334
Guidelines
167
Studies & Reports
77
Manuals
58
Strategic & Response Plan
35
Training Material
9
Fact sheets
8
Situation Updates
5
Resource Platforms
5
Brochures
1
Infographics
1
Countries / Regions
India
46
Sierra Leone
27
Latin America and the Carribbean
24
Nigeria
22
Global
19
Western and Central Europe
18
Africa
17
Liberia
17
Kenya
15
Rwanda
13
Uganda
13
Brazil
13
Ghana
12
Eastern Europe
11
Mozambique
10
West and Central Africa
10
Ethiopia
10
Nepal
9
Ukraine
9
Guinea
9
Syria
8
Congo, Democratic Republic of
8
Middle East and North Africa
8
East and Southern Africa
8
Angola
8
Zambia
8
Tanzania
7
Bangladesh
7
Philippines
6
South–East Asia Region
6
South Africa
6
Russia
6
Burkina Faso
5
Malawi
5
Pakistan
5
Guinea-Bissau
4
Western Pacific Region
4
Eastern Europe and Central Asia
4
Spain
4
Namibia
4
Yemen
4
Myanmar / Burma
4
Tajikistan
3
Chile
3
Senegal
3
Afghanistan
3
South Sudan
3
Colombia
2
Cameroon
2
Peru
2
USA
2
Cambodia
2
Germany
2
Saudi Arabia
2
Bolivia
2
Lebanon
2
Moldova
2
Sudan
2
Georgia
2
Central African Republic
2
North Macedonia
1
Mexico
1
Togo
1
China
1
Iran
1
Albania
1
Laos
1
Burundi
1
Zimbabwe
1
Morocco
1
Bulgaria
1
Mauritania
1
Italy
1
Armenia
1
Asia
1
Venezuela
1
Hungary
1
Jordan
1
Paraguay
1
North America
1
Gabon
1
Mauritius
1
Tunisia
1
Côte d’Ivoire / Ivory Coast
1
Argentina
1
Vietnam
1
Sri Lanka
1
Romania
1
Slovakia
1
Greece
1
Palestine
1
Poland
1
Mali
1
Chad
1
Libya
1
Bhutan
1
Indonesia
1
Iraq
1
Somalia
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
252
Pharmacy & Technologies
58
Clinical Guidelines
57
Key Resources
34
Public Health
27
Women & Child Health
7
Capacity Building
2
Toolboxes
COVID-19
156
TB
115
Rapid Response
88
Ebola & Marburg
72
AMR
39
NTDs
24
HIV
20
Planetary Health
16
Conflict
13
Zika
11
Pharmacy
10
Caregiver
9
Polio
9
Specific Hazards
7
Natural Hazards
5
Malaria
5
Mental Health
3
Cholera
3
Health Financing Toolbox
3
Refugee
1
Global Health Education
1
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
Antibiotics have been a critical public health tool since the discovery of Penicillin in 1928, saving the lives of millions of people around the world. In developing country like ours, where the burden of treatable disease is very high and access to health facilities and laboratories is difficult, a...
Due to the anticipated significant rise in VL testing occasioned by Ghana’s adaptation of 2016 ART guidelines, it has become necessary to develop this VL scale-up and operational plan to assure complete client access to laboratory monitoring towards the achievement of the third 90 of the HIV care ...
International health regulations (2005): state party self-assessment annual reporting tool, 2nd ed
Second edition.
AVailable in English, French, Spanish, Russian, Chinese and Portuguese
ECDC Technical Document
For biological agents, the publication covers 11 bacteria,
fungi and viruses listed by states parties to the Biological
Weapons Convention in declarations of past offensive
research and development programmes, or considered of
special concern for possible use in terrorism. All of these
agents c...
Cases of monkeypox (MPX) acquired in the EU have recently been reported in nine EU Member States (Austria, Belgium, France, Germany, Italy, Portugal, Spain, Sweden, and the Netherlands).
Monkeypox (MPX) does not spread easily between people. Human-to-human transmission occurs through close contact ...
Interim emergency guidelines
Rabies is a fatal viral zoonosis and serious public health problem.1 All mammals are believed to be susceptible to the disease, and for the purposes of this document, use of the term animal refers to mammals. The disease is an acute, progressive encephalitis caused by viruses in the genus Lyssavirus...
The overall objective of this implementation plan is to define the strategy for implementation of the Xpert MTB/RIF test for rapid detection of TB and rifampicin (RIF) resistance in Tanzania, within the context of the National Tuberculosis and Leprosy Programme (NTLP) strategic plan and other nation...
International Journal of Infectious Diseases 32 (2015) 111–117
orientations provisoires, 25 juin 2021. Des tests de diagnostic rapides et précis sont un outil essentiel pour prévenir et contrôler la propagation du COVID-19. Ce document décrit les recommandations relatives aux stratégies nationales de dépistage et à l'utilisation de la PCR et des tests an...
WHO Information Leaflet COVID-19: Considerations on tuberculosis (TB) care
This document aims to provide interim guidance for microbiology and virology experts, other laboratory professionals, laboratory managers, infectious disease programme managers, public health professionals and other stakeholders that provide primary, confirmatory or advanced testing for SARS-CoV-2, ...
The development of this target product profile (TPP) was led by the WHO Department of Control of Neglected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG) was form...
